National Asset Management, Inc. Aspira Women'S Health Inc. Transaction History

National Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$0.32 - $0.58 $41,491 - $75,203	129,662 Added 19.55%	792,728 $293,000
Q4 2022 Feb 21, 2023	SELL	$0.3 - $0.41 $5,820 - $7,955	-19,403 Reduced 2.84%	663,066 $218,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $1.07 $259,338 - $730,241	682,469 New	682,469 $255,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.